Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sancy A Leachman

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Value in Health Regional Issues|June 30, 2026
Cost-Effectiveness of Vaccine for the Prevention of Herpes Zoster in Kidney Transplant Recipients in ThailandTeerapon Dhippayom, Piyameth Dilokthornsakul, Jeong-Yeon Cho, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 26, 2014
Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testingLisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma familiesLisa G Aspinwall, Samantha L Leaf, Erin R Dola, et al.
Psycho-Oncology|February 6, 2013
Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcomeLisa G Aspinwall, Jennifer M Taber, Samantha L Leaf, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2013
Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years laterLisa G Aspinwall, Jennifer M Taber, Samantha L Leaf, et al.
Journal of Genetic Counseling|December 11, 2013
Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recallLisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, et al.
Journal of the American Academy of Dermatology|March 13, 2009
Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counselingLisa G Aspinwall, Samantha L Leaf, Wendy Kohlmann, et al.
Dermatology Nursing|May 29, 2007
Management of melanoma during pregnancySancy A Leachman, Ryan Jackson, Mark J Eliason, et al.
Journal of Dermatological Science|August 25, 2009
Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patientsRobyn P Hickerson, Devin Leake, Lana N Pho, et al.
Journal of the American Academy of Dermatology|October 16, 2013
Partner involvement in conduct of skin self-examinations remains low following CDKN2A/p16 genetic test reporting and counselingJennifer M Taber, Lisa G Aspinwall, Samantha L Leaf, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Value in Health Regional Issues|June 30, 2026
Cost-Effectiveness of Vaccine for the Prevention of Herpes Zoster in Kidney Transplant Recipients in ThailandTeerapon Dhippayom, Piyameth Dilokthornsakul, Jeong-Yeon Cho, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 26, 2014
Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testingLisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma familiesLisa G Aspinwall, Samantha L Leaf, Erin R Dola, et al.
Psycho-Oncology|February 6, 2013
Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcomeLisa G Aspinwall, Jennifer M Taber, Samantha L Leaf, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2013
Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years laterLisa G Aspinwall, Jennifer M Taber, Samantha L Leaf, et al.
Journal of Genetic Counseling|December 11, 2013
Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recallLisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, et al.
Journal of the American Academy of Dermatology|March 13, 2009
Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counselingLisa G Aspinwall, Samantha L Leaf, Wendy Kohlmann, et al.
Dermatology Nursing|May 29, 2007
Management of melanoma during pregnancySancy A Leachman, Ryan Jackson, Mark J Eliason, et al.
Journal of Dermatological Science|August 25, 2009
Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patientsRobyn P Hickerson, Devin Leake, Lana N Pho, et al.
Journal of the American Academy of Dermatology|October 16, 2013
Partner involvement in conduct of skin self-examinations remains low following CDKN2A/p16 genetic test reporting and counselingJennifer M Taber, Lisa G Aspinwall, Samantha L Leaf, et al.
Pageof 18